by Elena Iemma | Oct 22, 2025 | Blog
The Power of Tregs: From Sakaguchi’s Nobel Discovery to EpiVax Innovation If you know us, you know we love Tregs. Regulatory T cells (Tregs) are central to how we think about the immune system and nearly everything we do at EpiVax. So, we were thrilled to see this...
by Annie De Groot | Feb 26, 2019 | Events
2nd Antigen-Specific Immune Tolerance Drug Development Summit Tuesday, March 26th – Thursday, March 28th, 2019 Wyndham Boston Beacon Hill 5 Blossom Street Boston, Massachusetts 02114 USA Join Dr. Annie De Groot, CEO/CSO EpiVax, at the 2nd Antigen-Specific Immune...
